Hepatitis C virus infection during pregnancy and the newborn period - are they opportunities for treatment?
Total and cause-specific mortality rates in a prospective study of community-acquired hepatitis C virus infection in northern Norway
Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3 infection
Quality of life in patients with various liver diseases
Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots
Controlled release recombinant human interferon-α2b for treating patients with chronic hepatitis C genotype 1: a phase 2a clinical trial
Mutations in the core and NS5A region of hepatitis C virus genotype 1b and correlation with response to pegylated-interferon-alpha 2b and ribavirin combination therapy
Virologic and biochemical responses to clevudine in patients with chronic HBV infection- associated cirrhosis: data at week 48
Clinical, epidemiological characteristics and indications for liver biopsy and treatment in immigrants with chronic hepatitis B at a referral hospital in Madrid
Single-step real-time PCR to quantify hepatitis B virus and distinguish genotype D from non-D genotypes
Hepatitis A outbreaks: the effect of a mass vaccination programme
Comparative immunogenicity of two vaccination schedules of a combined hepatitis A and B vaccine in healthy volunteers
Distinct geographical and demographic distribution of hepatitis B virus genotypes in the Canadian Arctic as revealed through an extensive molecular epidemiological survey
An outbreak of hepatitis B with high mortality in India: association with precore, basal core promoter mutants and improperly sterilized syringes
Genotypic resistance profile of hepatitis B virus (HBV) in a large cohort of nucleos(t)ide analogue-experienced Chinese patients with chronic HBV infection
Hepatitis B in the Greater San Francisco Bay Area: an integrated programme to respond to a diverse local epidemic
Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients
Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007
Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort
The optimal cut-off for predicting large oesophageal varices using transient elastography is disease specific
Estimating the likelihood of sustained virological response in chronic hepatitis C therapy
The association of cryoglobulinaemia with sustained virological response in patients with chronic hepatitis C
Extended treatment duration for treatment naïve chronic hepatitis C genotype 1 late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of pegylated interferon and ribavirin
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia
Correlation between mutations in the core and NS5A genes of hepatitis C virus genotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirin combination therapy
The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow’s injecting drug user population
Hepatitis C treatment among racial and ethnic groups in the IDEAL trial
Serum lipids and their associations with viral levels and liver disease severity in a treatment-naïve chronic hepatitis C type 1-infected cohort
GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection
Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis